UBS Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-221,597
| Closed | -$4.18M | – | 7503 |
|
|
2019
Q3 | $4.18M | Buy |
221,597
+171,442
| +342% | +$3.23M | ﹤0.01% | 1999 |
|
|
2019
Q2 | $591K | Sell |
50,155
-71,682
| -59% | -$845K | ﹤0.01% | 3427 |
|
|
2019
Q1 | $1.66M | Buy |
121,837
+20,005
| +20% | +$273K | ﹤0.01% | 2561 |
|
|
2018
Q4 | $1.04M | Buy |
101,832
+81,456
| +400% | +$834K | ﹤0.01% | 2960 |
|
|
2018
Q3 | $339K | Buy |
20,376
+17,288
| +560% | +$288K | ﹤0.01% | 3881 |
|
|
2018
Q2 | $49K | Sell |
3,088
-225,749
| -99% | -$3.58M | ﹤0.01% | 5084 |
|
|
2018
Q1 | $2.91M | Buy |
228,837
+212,303
| +1,284% | +$2.7M | ﹤0.01% | 2254 |
|
|
2017
Q4 | $189K | Sell |
16,534
-60,476
| -79% | -$691K | ﹤0.01% | 4049 |
|
|
2017
Q3 | $943K | Buy |
77,010
+76,003
| +7,547% | +$931K | ﹤0.01% | 3047 |
|
|
2017
Q2 | $12K | Sell |
1,007
-610
| -38% | -$7.27K | ﹤0.01% | 5732 |
|
|
2017
Q1 | $33K | Sell |
1,617
-35,696
| -96% | -$728K | ﹤0.01% | 4895 |
|
|
2016
Q4 | $776K | Buy |
37,313
+36,459
| +4,269% | +$758K | ﹤0.01% | 3003 |
|
|
2016
Q3 | $28K | Sell |
854
-782
| -48% | -$25.6K | ﹤0.01% | 5136 |
|
|
2016
Q2 | $41K | Sell |
1,636
-9,493
| -85% | -$238K | ﹤0.01% | 4817 |
|
|
2016
Q1 | $272K | Sell |
11,129
-12,803
| -53% | -$313K | ﹤0.01% | 3574 |
|
|
2015
Q4 | $791K | Sell |
23,932
-91,249
| -79% | -$3.02M | ﹤0.01% | 2841 |
|
|
2015
Q3 | $3.77M | Sell |
115,181
-20,422
| -15% | -$669K | ﹤0.01% | 1689 |
|
|
2015
Q2 | $7.18M | Buy |
+135,603
| New | +$7.18M | ﹤0.01% | 1354 |
|